Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir vs Atazanavir in treatment-naive HIV patients
NCT00762892Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Jan 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by UTHealth Houston. Started Jan 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00762892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762892.